Clinical efficacy and recovery levels of recombinant FVIIa (NovoSeven) in the treatment of intracranial haemorrhage in severe neonatal FVII deficiency.
Recombinant factor VIIa in the treatment of bleeding in hemophilic children with inhibitors.
Recombinant activated factor VII in children with acute bleeding resulting from liver failure and disseminated intravascular coagulation.
Synthetic factor VIIa to treat dilutional coagulopathy during posterior spinal fusion in two children.
Prescribing Info - Questions - Drug Info - Links - PDA Software - Article Summaries - Slideshows - Review Articles - What's New
© Copyright 1999-2020 All Rights Reserved.